{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:00:47Z","timestamp":1762210847410},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136635","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T18:41:17Z","timestamp":1440787277000},"page":"e0136635","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection"],"prefix":"10.1371","volume":"10","author":[{"given":"Neha","family":"Dalmia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair J.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box","volume":"33","author":"SH Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"ref2","article-title":"Global Tuberculosis Report 2014"},{"key":"ref3","first-page":"156","article-title":"Vaccine strategies against tuberculosis","volume":"139","author":"H McShane","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature","volume":"271","author":"GA Colditz","year":"1994","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guerin Vaccination of Newborns","volume":"182","author":"BMN Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"AC Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"JL Flynn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"AM Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/eji.1830271215","article-title":"High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: Synergistic action of TNF and IFN-\u03b3 in the differentiation of protective granulomas","volume":"27","author":"I Garcia","year":"1997","journal-title":"Eur J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2","volume":"192","author":"CA Scanga","year":"2000","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.0818-9641.2002.01143.x","article-title":"Improving vaccines against tuberculosis","volume":"81","author":"WJ Britton","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical and clinical advances","volume":"12","author":"JB Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.165.5.2850","article-title":"Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice","volume":"165","author":"M Dupuis","year":"2000","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI200319069","article-title":"DNA vaccines and apoptosis: to kill or not to kill?","volume":"112","author":"WW Leitner","year":"2003","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nbt0704-799","article-title":"DNA vaccines-back in the saddle again?","volume":"22","author":"K Powell","year":"2004","journal-title":"Nat Biotechnol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e29231","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"SA Kalams","year":"2012","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/CMR.17.2.370-389.2004","article-title":"DNA vaccines against human immunodeficiency virus type 1 in the past decade","volume":"17","author":"M Giri","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.vaccine.2005.08.048","article-title":"Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis","volume":"24","author":"SC Gilbert","year":"2006","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2007.12.060","article-title":"Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers","volume":"26","author":"S Wang","year":"2008","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2005.08.021","article-title":"DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates","volume":"24","author":"Z Li","year":"2006","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1016\/j.vaccine.2008.03.090","article-title":"Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation","volume":"26","author":"M Rosati","year":"2008","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/icb.2010.25","article-title":"Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis","volume":"88","author":"SL Young","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"S Lu","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13412","DOI":"10.1128\/JVI.01799-07","article-title":"Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine","volume":"81","author":"K Ljungberg","year":"2007","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nbt0698-562","article-title":"Enhancing immune responses using suicidal DNA vaccines","volume":"16","author":"P Berglund","year":"1998","journal-title":"Nat Biotechnol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/IAI.71.1.575-579.2003","article-title":"Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A","volume":"71","author":"JR Kirman","year":"2003","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1128\/IAI.73.11.7727-7735.2005","article-title":"Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis","volume":"73","author":"SC Derrick","year":"2005","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1017\/S1462399408000859","article-title":"Therapeutic and prophylactic applications of alphavirus vectors","volume":"10","author":"GJ Atkins","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1128\/JVI.06535-11","article-title":"Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine","volume":"86","author":"ML Knudsen","year":"2012","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0600287103","article-title":"Mucosal and systemic adjuvant activity of alphavirus replicon particles","volume":"103","author":"JM Thompson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.vaccine.2008.05.046","article-title":"Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen","volume":"26","author":"JM Thompson","year":"2008","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1128\/JVI.74.24.11849-11857.2000","article-title":"Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein","volume":"74","author":"JP Gardner","year":"2000","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/JVI.74.2.914-922.2000","article-title":"Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis","volume":"74","author":"GH MacDonald","year":"2000","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1099\/vir.0.007336-0","article-title":"PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response","volume":"90","author":"G Barry","year":"2009","journal-title":"J Gen Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"O Schulz","year":"2005","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1128\/JVI.02310-09","article-title":"Semliki forest virus-induced endoplasmic reticulum stress accelerates apoptotic death of mammalian cells","volume":"84","author":"G Barry","year":"2010","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/08830180490265529","article-title":"Alphaviruses and apoptosis","volume":"23","author":"ML Li","year":"2004","journal-title":"Int Rev Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"JT Belisle","year":"1997","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","article-title":"Nonreplicating persistence of Mycobacterium Tuberculosis","volume":"55","author":"LG Wayne","year":"2001","journal-title":"Ann Rev Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/IAI.70.3.1518-1529.2002","article-title":"Identification of a Mycobacterium tuberculosis Putative Classical Nitroreductase Gene Whose Expression Is Coregulated with That of the acr Gene within Macrophages, in Standing versus Shaking Cultures, and under Low Oxygen Conditions","volume":"70","author":"A Purkayastha","year":"2002","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2012.02.020","article-title":"CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals","volume":"30","author":"MW Auten","year":"2012","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"P Pushko","year":"1997","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1128\/JVI.74.22.10623-10630.2000","article-title":"Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"UB Balasuriya","year":"2000","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1128\/JVI.01209-09","article-title":"Similarities and differences in antagonism of neuron alpha\/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses","volume":"83","author":"J Yin","year":"2009","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1128\/JVI.01282-07","article-title":"Identification and characterization of interferon-induced proteins that inhibit alphavirus replication","volume":"81","author":"Y Zhang","year":"2007","journal-title":"J Virol"},{"key":"ref46","first-page":"6","article-title":"Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells","volume":"80","author":"HM Vordermeier","year":"1993","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/IAI.01137-06","article-title":"Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice","volume":"75","author":"V Roupie","year":"2007","journal-title":"Infect Immun"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis","volume":"71","author":"S D'Souza","year":"2003","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"K Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"IM Belyakov","year":"2009","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity","volume":"19","author":"L Haan","year":"2001","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"PA Darrah","year":"2007","journal-title":"Nat Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.4049\/jimmunol.179.7.4732","article-title":"Live Attenuated Lentivirus Infection Elicits Polyfunctional Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells with Reduced Apoptotic Susceptibility in Rhesus Macaques that Control Virus Replication after Challenge with Pathogenic SIVmac239","volume":"179","author":"M Genesca","year":"2007","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice","volume":"181","author":"EK Forbes","year":"2008","journal-title":"J Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.200907-1011OC","article-title":"HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria","volume":"180","author":"B Kalsdorf","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/eji.200838693","article-title":"Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease","volume":"39","author":"JS Sutherland","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/eji.201040731","article-title":"Polyfunctional T cells in human tuberculosis","volume":"40","author":"KA Wilkinson","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/mi.2013.99","article-title":"Harnessing local and systemic immunity for vaccines against tuberculosis","volume":"7","author":"PC Beverley","year":"2014","journal-title":"Mucosal Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"IA Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.12.94","article-title":"Prime-boost approaches to tuberculosis vaccine development","volume":"11","author":"N Dalmia","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette-Guerin","volume":"366","author":"H McShane","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"MD Tameris","year":"2013","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mi.2012.103","article-title":"Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity","volume":"6","author":"M Jeyanathan","year":"2013","journal-title":"Mucosal Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e5856","DOI":"10.1371\/journal.pone.0005856","article-title":"Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis","volume":"4","author":"Z Xing","year":"2009","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guerin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara","volume":"171","author":"NP Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.micinf.2007.07.009","article-title":"Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines","volume":"9","author":"GT Brice","year":"2007","journal-title":"Microbes Infect"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1371\/journal.pone.0001063","article-title":"Protection of rhesus monkeys by a DNA prime\/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens","volume":"2","author":"WR Weiss","year":"2007","journal-title":"PLoS One"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1128\/jb.178.15.4484-4492.1996","article-title":"Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog","volume":"178","author":"Y Yuan","year":"1996","journal-title":"J Bacteriol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1073\/pnas.0136863100","article-title":"Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence","volume":"100","author":"L Shi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"C Aagaard","year":"2011","journal-title":"Nat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T15:04:19Z","timestamp":1540220659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136635"}},"subtitle":[],"editor":[{"given":"Anil Kumar","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136635","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}